Polycystic ovary syndrome is associated with higher left ventricular mass index: the CARDIA women's study
- PMID: 23012389
- PMCID: PMC3591678
- DOI: 10.1210/jc.2012-1597
Polycystic ovary syndrome is associated with higher left ventricular mass index: the CARDIA women's study
Abstract
Objective: The aim of the study was to determine whether young women with polycystic ovary syndrome (PCOS) have evidence of early structural changes in echocardiographic parameters as a measurement of cardiovascular risk.
Methods: We investigated the association of PCOS and echocardiographic parameters in 984 black and white women in the Coronary Artery Risk Development in Young Adults (CARDIA) study, a cohort followed prospectively for 20 yr. Women ages 34-46 (Year 16) completed questionnaires recalling symptoms of oligomenorrhea and hirsutism in their 20s and 30s. Serum androgens were obtained at Year 2. Women in their 20s and 30s were classified into four mutually exclusive groups: 1) PCOS; 2) isolated oligomenorrhea (IO); 3) isolated hyperandrogenism (IH); and 4) reference group. Outcome measures were defined as echocardiography data from Year 5. We used multivariable linear regression models to evaluate the association of PCOS and its components with left ventricular (LV) mass index, left atrial (LA) diameter, LV ejection fraction (LVEF), and mitral inflow early wave to late wave ratio.
Results: Among 984 participants, 42 women (4.3%) were classified as PCOS, 67 (6.8%) as IO, and 178 (18.0%) as IH. In multivariable linear regression analyses, women with PCOS had a 3.14 g/m(2.7) (95% confidence interval, 0.48-5.81) higher LV mass index compared to the reference group (approximately 10% higher). PCOS women also had a 0.11 cm/m (95% confidence interval, 0.02-0.19) larger LA diameter, after adjustment for age and race.
Conclusion: PCOS, but not IO or IH, is associated with a higher LV mass index and larger LA diameter in young women, suggestive of early adverse cardiac remodeling. Additional longitudinal studies are needed to evaluate whether this difference persists over time.
Similar articles
-
Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the Coronary Artery Risk Development in Young Adults Women's study.Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2688-94. doi: 10.1161/ATVBAHA.114.304136. Epub 2014 Oct 30. Arterioscler Thromb Vasc Biol. 2014. PMID: 25359859
-
Race-ethnic and sex differences in left ventricular structure and function: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.J Am Heart Assoc. 2015 Mar 13;4(3):e001264. doi: 10.1161/JAHA.114.001264. J Am Heart Assoc. 2015. PMID: 25770024 Free PMC article.
-
Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults.Circulation. 1995 Aug 1;92(3):380-7. doi: 10.1161/01.cir.92.3.380. Circulation. 1995. PMID: 7634452
-
Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome.Cochrane Database Syst Rev. 2020 Aug 13;8(8):CD005552. doi: 10.1002/14651858.CD005552.pub3. Cochrane Database Syst Rev. 2020. PMID: 32794179 Free PMC article.
-
Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives.Atherosclerosis. 2006 Apr;185(2):227-39. doi: 10.1016/j.atherosclerosis.2005.10.007. Epub 2005 Nov 28. Atherosclerosis. 2006. PMID: 16313910 Review.
Cited by
-
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.Endocr Rev. 2015 Oct;36(5):487-525. doi: 10.1210/er.2015-1018. Endocr Rev. 2015. PMID: 26426951 Free PMC article. Review.
-
Approach to Interpreting Common Laboratory Pathology Tests in Transgender Individuals.J Clin Endocrinol Metab. 2021 Mar 8;106(3):893-901. doi: 10.1210/clinem/dgaa546. J Clin Endocrinol Metab. 2021. PMID: 32810277 Free PMC article. Review.
-
Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife.Am J Gastroenterol. 2017 May;112(5):755-762. doi: 10.1038/ajg.2017.44. Epub 2017 Mar 14. Am J Gastroenterol. 2017. PMID: 28291240 Free PMC article.
-
Self-Reported Polycystic Ovary Syndrome Is Associated With Hypertension: A Northern Finland Birth Cohort 1966 Study.J Clin Endocrinol Metab. 2019 Apr 1;104(4):1221-1231. doi: 10.1210/jc.2018-00570. J Clin Endocrinol Metab. 2019. PMID: 30445634 Free PMC article.
-
Machine learning classification of polycystic ovary syndrome based on radial pulse wave analysis.BMC Complement Med Ther. 2023 Nov 13;23(1):409. doi: 10.1186/s12906-023-04249-5. BMC Complement Med Ther. 2023. PMID: 37957660 Free PMC article.
References
-
- Zawadski J, Dunaif A. 1992. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens J, Haseltine F, Merriam G, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications; 377–384
-
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47 - PubMed
-
- Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF. 2009. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91:456–488 - PubMed
-
- Lo JC, Feigenbaum SL, Yang J, Pressman AR, Selby JV, Go AS. 2006. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab 91:1357–1363 - PubMed
-
- Holte J, Gennarelli G, Berne C, Bergh T, Lithell H. 1996. Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state? Hum Reprod 11:23–28 - PubMed
Publication types
MeSH terms
Grants and funding
- N01-HC-05187/HC/NHLBI NIH HHS/United States
- N01 HC048048/HL/NHLBI NIH HHS/United States
- N01-HC-48047/HC/NHLBI NIH HHS/United States
- N01-HC-95095/HC/NHLBI NIH HHS/United States
- N01-HC-48049/HC/NHLBI NIH HHS/United States
- N01 HC048047/HL/NHLBI NIH HHS/United States
- N01 HC048050/HL/NHLBI NIH HHS/United States
- N01-HC-48048/HC/NHLBI NIH HHS/United States
- N01 HC045204/HL/NHLBI NIH HHS/United States
- N01 HC095095/HL/NHLBI NIH HHS/United States
- N01-HC-45205/HC/NHLBI NIH HHS/United States
- N01-HC-45204/HC/NHLBI NIH HHS/United States
- N01 HC048049/HL/NHLBI NIH HHS/United States
- N01-HC-48050/HC/NHLBI NIH HHS/United States
- N01 HC045205/HL/NHLBI NIH HHS/United States
- N01 HC005187/HL/NHLBI NIH HHS/United States
- N01 HC045134/HC/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical